Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN

Overview of attention for article published in New England Journal of Medicine, December 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 25 news outlets
blogs: 2 blogs
twitter: 143 X users
facebook: 1 Facebook page

reddit: 1 Redditor
bluesky: 27 Bluesky users
podcasts: 2 podcasts

Readers on

mendeley: 58 Mendeley

So far, Altmetric has seen 36 Bluesky posts from 27 Bluesky users, with an upper bound of 54,015 followers.

RP @nephjc.bsky.social: 1/10 Last #NephJC we discussed Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN #TenPostNephJC Given the central role of complement dysregulation in C3 glomerulonephritis, we assessed whether complement-targeted therap…

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity, including 32 additional Bluesky posts.